Cargando…
Advancements in PARP1 Targeted Nuclear Imaging and Theranostic Probes
The central paradigm of novel therapeutic approaches in cancer therapy is identifying and targeting molecular biomarkers. One such target is the nuclear DNA repair enzyme Poly-(ADP ribose) polymerase 1 (PARP1). Sensitivity to PARP inhibition in certain cancers such as gBRCA(mut) breast and ovarian c...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408801/ https://www.ncbi.nlm.nih.gov/pubmed/32640708 http://dx.doi.org/10.3390/jcm9072130 |